Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Ethinyl Estradiol; Norethindrone Patent Expiration

Ethinyl Estradiol; Norethindrone is Used for preventing pregnancy in women using oral contraceptives. It was first introduced by Ortho Mcneil Pharmaceutical Inc in its drug Modicon 21 on Approved Prior to Jan 1, 1982. Other drugs containing Ethinyl Estradiol; Norethindrone are Ortho-Novum 7/14-28, Norethindrone And Ethinyl Estradiol And Ferrous Fumarate, Ortho-Novum 7/7/7-28, Tri-Norinyl 28-Day, Modicon 28, Norinyl 1+35 28-Day, Ovcon-35, Ortho-Novum 7/7/7-21, Ortho-Novum 10/11-28, Ortho-Novum 1/35-21, Femcon Fe, Brevicon 28-Day, Ovcon-50, Ortho-Novum 1/35-28, Ortho-Novum 7/14-21, Norinyl 1+35 21-Day, Brevicon 21-Day, Ortho-Novum 10/11-21, Tri-Norinyl 21-Day. 24 different companies have introduced drugs containing Ethinyl Estradiol; Norethindrone.


Ethinyl Estradiol; Norethindrone Patents

Given below is the list of patents protecting Ethinyl Estradiol; Norethindrone, along with the drug name that holds that patent and the company name owning that drug.

Filter patents by

Country : United States (US)
Patent Category : All
Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Femcon Fe US6667050 Chewable oral contraceptive Apr 06, 2019

(Expired)

 Apil
Norethindrone And Ethinyl Estradiol And Ferrous Fumarate US6667050 Chewable oral contraceptive Apr 06, 2019

(Expired)

 Teva Branded Pharm
Norethindrone And Ethinyl Estradiol And Ferrous Fumarate US5552394 Low dose oral contraceptives with less breakthrough bleeding and sustained efficacy Jul 22, 2014

(Expired)

 Teva Branded Pharm



Ethinyl Estradiol; Norethindrone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Ethinyl Estradiol; Norethindrone Generic API Manufacturers

Several generic applications have been filed for Ethinyl Estradiol; Norethindrone. The first generic version for Ethinyl Estradiol; Norethindrone was by Watson Pharmaceuticals Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc and was approved on Jan 29, 1987. And the latest generic version is by Aurobindo Pharma Ltd and was approved on Oct 11, 2022.

Given below is the list of companies who have filed for Ethinyl Estradiol; Norethindrone generic, along with the locations of their manufacturing plants worldwide.